title: The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.
abstract: Decreased survival in patients with cystic fibrosis has been related to FEV1, BMI, and infection with Burkholderia cepacia complex (BCC). We have assessed the relationship of blood, sputum, and urine inflammatory markers to lung function, BMI, colonization with B cenocepacia (Bc), and patient survival. Thirty-nine stable cystic fibrosis (CF) patients (10 with Bc) were enrolled in a study to determine the effect of alpha-1-antitrypsin on airways inflammation. Pre-treatment measurements were used in this study. Demographics, sputum microbiology, heart rate, oxygen saturation, lung function were recorded. Blood samples were obtained for white blood count (WBC), C-Reactive Protein (CRP), and plasma neutrophil elastase/AAT complexes (pNEC). Neutrophil elastase (NE), neutrophil elastase/AAT complexes (sNEC), interleukin-8 (IL-8), TNF-receptor 1 (sTNFr), and myeloperoxidase (MPO) were measured in sputum and urinary desmosine concentration determined. Patients with Bc had significantly higher levels of pNEC, 332 +/- 91.4 ng/ml (mean +/- SEM) versus 106 +/- 18.2 ng/ml (P = 0.0005) and sNEC, 369 +/- 76.6 ng/ml versus 197 +/- 36.0 ng/ml compared to those who were not. Five deaths were reported at the end of 1 year, (four with Bc) (P = 0.011). Patients who subsequently died had significantly lower lung function FEV1, 1.2 +/- 0.2 L versus 2.0 +/- 0.1 L (P = 0.03) and FVC, 2 +/- 0.3 L versus 3.1 +/- 0.2 L (P = 0.01), compared to those that survived. There was significantly higher NE activity, 3.6 +/- 1.6 U/ml versus 1.5 +/- 0.6 U/ml (P = 0.03), pNEC, 274 +/- 99 ng/ml versus 142 +/- 30 ng/ml (P = 0.05), MPO, 163 +/- 62 mcg/ml versus 54 +/- 6.9 mcg/ml (P = 0.03), and urinary desmosines 108 +/- 19.9 pM/mg creatinine versus 51.1 +/- 3.3 pM/mg creatinine (P = 0.001), in those patients who subsequently died compared to those that survived. These data suggest there is increased neutrophil degranulation in patients infected with Bc and these patients have a poor outcome.
authors.affiliation: Adult Cystic Fibrosis Centre, Belfast City Hospital and Queens University, Belfast, Northern Ireland.
authors.forename: Damian G
authors.initials: DG
authors.lastname: Downey
authors.forename: S Lorraine
authors.initials: SL
authors.lastname: Martin
authors.forename: Martin
authors.initials: M
authors.lastname: Dempster
authors.forename: John E
authors.initials: JE
authors.lastname: Moore
authors.forename: Mary T
authors.initials: MT
authors.lastname: Keogan
authors.forename: Barry
authors.initials: B
authors.lastname: Starcher
authors.forename: Julia
authors.initials: J
authors.lastname: Edgar
authors.forename: Diana
authors.initials: D
authors.lastname: Bilton
authors.forename: J Stuart
authors.initials: JS
authors.lastname: Elborn
mesh_terms: D015415:Biomarkers / Q000097:blood / Q000652:urine; D016956:Burkholderia cepacia / Q000302:isolation & purification; D003550:Cystic Fibrosis / Q000097:blood* / Q000276:immunology / Q000652:urine*; D006801:Humans; D007249:Inflammation; D011446:Prospective Studies; D013183:Sputum / Q000737:chemistry*; D015996:Survival Rate
chemical_list: D015415:Biomarkers